2025
2025 BSCR Autumn Meeting: Frontiers in Cardiovascular Research
18 June 2025
The 2025 British Society for Cardiovascular Research (BSCR) Autumn Meeting, 'Frontiers in Cardiovascular Research’, will take place at William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, on the Charterhouse Square campus.
Queen Mary Emeritus Professor awarded CBE in King’s Birthday Honours
16 June 2025
Professor Tilli Tansey recognised for her contribution to medical history and science.
Largest twin study explores whether the environment affects people differently depending on their genes
10 June 2025
An international team including researchers from Queen Mary have identified genetic factors that may make some individuals more or less sensitive to the environments they experience.
Queen Mary University of London to lead EU-wide Resolution Biology network
2 June 2025
Queen Mary University of London will lead a new European research initiative, following the successful award of a highly competitive grant from the European Cooperation in Science and Technology (COST) framework.
New injection could help millions with high blood pressure
29 May 2025
Results from a clinical trial led by researchers from Queen Mary University of London, published yesterday in JAMA, show that giving people with high blood pressure an injection every six months can lead to a meaningful, sustained reduction in their blood pressure.
Professor Morris Brown elected as Fellow of the Royal Society
20 May 2025
Professor Morris Brown MD FRCP FMedSci FRS has been elected to the Fellowship of the Royal Society, the UK’s national academy of sciences. He is one of 90 outstanding scientists from the UK and internationally who have joined the prestigious body this year.
Queen Mary and Research Grid collaboration trials AI technology to improve efficiency in clinical trials
12 May 2025
A project led by Queen Mary University of London, in partnership with Research Grid, Barts Health NHS Trust and the Royal Academy of Engineering, has successfully trialled a new AI-driven approach to automate clinical trial data entry, that could dramatically reduce the time and cost of running clinical trials.
Professor Sir Mark Caulfield elected member of the Medical Research Council
2 April 2025
Professor Caulfield, Professor of Clinical Pharmacology and Vice-Principal (Health) at Queen Mary, joins twelve other senior figures from health, science, and medicine on the Council.
Testing patients for just three genes could help prevent three quarters of avoidable side effects of certain medications
28 March 2025
A new study from Queen Mary University of London found that 9% of all adverse drug reactions (ADRs) reported to the UK medicines regulator are associated with medications where side effect risk is partly dependent on patient’s genes. Of this subset of ADRs, 75% were associated with only three genes that impact how the body processes medication. Genetic testing before prescribing could therefore help avoid ADRs in these cases.
Underfunding may contribute to higher mortality for patients in Latin America receiving surgery
27 March 2025
An international study of the health outcomes of people receiving surgery across 17 Latin American countries found 1 in 7 developed significant complications leading to longer hospital stays and a greater risk of death.
New study of critically ill patients in Africa finds that lives could be saved with improvements to hospitals’ emergency and critical care treatments
An international study of acute hospitals across Africa found a large and neglected burden of critical illness, and a high incidence of preventable deaths due to issues with the provision of basic critical care.
New adrenal stem cell marker may improve diagnosis and treatment of adrenal cancer
4 March 2025
A large international study led by researchers at Queen Mary University of London has identified a new biomarker that could support the diagnosis and treatment of adrenal cancer.
From height to health: largest global genetic study reveals hidden risks and benefits linked to stature
3 March 2025
New genetic links have been discovered between genetically-predicted height and an individual’s likelihood of developing a range of diseases and conditions. These new data could help improve early diagnosis and risk monitoring for patients.
Landmark study finds 69 previously unidentified genetic determinants of rare disease
27 February 2025
The breakthrough research led by Queen Mary University of London uses a new analytical approach for identifying the genetic basis of rare diseases, which could diagnose more cases and help develop new treatments for patients.
Almost 90% of people would agree to genetic testing to tailor medication use, survey finds
20 February 2025
- New research shows almost 90% of people in England would agree to genetic testing to get the most effective medication and reduce the risk of side effects
- 85% thought that the NHS should offer pharmacogenomic testing to people with multiple health conditions
- 58% of people thought that the NHS should offer this testing to everyone
- 91% wanted access to their own pharmacogenomic data, with many wanting this via the NHS app
New treatment offers quick cure for common cause of high blood pressure
10 February 2025
A revolutionary new treatment called Targeted Thermal Therapy (Triple T) offers a safer, faster alternative to surgery for patients with high blood pressure caused by Primary Aldosteronism, a hormonal disorder.
Professor Steffen Petersen awarded 2025 SCMR Gold Medal for excellence in cardiovascular medicine
3 February 2025
Steffen Petersen, Professor of Cardiovascular Medicine at Queen Mary University of London, has been honoured with the Society for Cardiovascular Magnetic Resonance (SCMR) Gold Medal Award. This prestigious recognition celebrates his outstanding contributions to the field of Cardiovascular Magnetic Resonance (CMR). Professor Petersen received the award on January 31, 2025, at the SCMR annual conference held in Washington, DC.
Queen Mary University of London is playing a key role in major new European research initiative to combat Multi-Drug Resistant Rheumatoid Arthritis (MDR-RA)
The MDR-RA (Multi-Drug Resistance in Rheumatoid Arthritis) project, with a total budget of €8.4 million, is funded by the European Union under the Horizon Europe programme and the Swiss State Secretariat for Education, Research, and Innovation.
New study shows AI can improve thyroid cancer diagnosis with artificially created images
7 January 2025
Researchers at Queen Mary University of London have found a new way to improve the accuracy of thyroid cancer diagnoses using artificial intelligence (AI). The study used a special type of approach, called Generative Adversarial Networks (GANs), to create realistic images of thyroid tissue samples. These fake images were then used to train AI systems to better detect cancer pathologies in real-life samples, potentially leading to more accurate diagnoses.
Doctors warn against fluid therapy approach in surgery after global trial
6 January 2025
A major study aiming to improve outcomes from higher risk operations has ruled out a fluid therapy approach during surgery.